论文部分内容阅读
１９９８年１０月～１９９９年４月我科应用万乃洛韦（丽珠威）和阿昔洛韦口服治疗带状疱疹进行了临床疗效对比观察 ,评价其有效性和安全性。现将结果报告如下。１临床资料共治疗带状疱疹９４例 ,并分为两组 ,丽珠威组（治疗组）４９例 ,男２５例 ,女２４例。年龄１４～６５岁
From October 1998 to April 1999, we compared the clinical efficacy of valacyclovir (Livzon) and acyclovir for the treatment of shingles, and evaluated its efficacy and safety. The results reported below. Clinical data A total of 94 cases of shingles were treated and divided into two groups, 49 cases of Livzon group (treatment group), 25 males and 24 females. Age 14 to 65 years old